Allergan is a global pharmaceutical company focused on developing, manufacturing and commercializing pharmaceuticals, devices, and biologic products for patients around the world. A $16 billion company, Allergan has operations in approximately 100 countries, supported by 13 manufacturing facilities and 12 R&D facilities worldwide.
After a series of mergers and divestitures, Allergan was left with a complicated and disparate landscape of business systems and processes. With more than 10,000 SKUs distributed over 100 countries, it was imperative to consolidate global demand, develop a unified process, and implement a single supply chain solution to be used company-wide.
How did Allergan transform their supply chain? Read this case study and find out how the pharmaceutical company was able to:
- Consolidate global demand planning down to the country SKU level, across 45 countries for their two largest markets
- Eliminate 35-40 touchpoints of incoming data from their distributor network and allow commercial partners to securely forecast using one integrated dashboard
- Retire a vast number of spreadsheets that were being maintained and updated manually